1. Home
  2. SLMT vs CPHI Comparison

SLMT vs CPHI Comparison

Compare SLMT & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brera Holdings PLC Class B Ordinary Shares

SLMT

Brera Holdings PLC Class B Ordinary Shares

HOLD

Current Price

$3.69

Market Cap

39.1M

Sector

N/A

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$0.65

Market Cap

41.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLMT
CPHI
Founded
2000
N/A
Country
Ireland
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
41.3M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
SLMT
CPHI
Price
$3.69
$0.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
65.4K
★ 3.8M
Earning Date
12-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,144,268.00
Revenue This Year
$203.36
N/A
Revenue Next Year
$9.67
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.56
$0.38
52 Week High
$11.77
$19.19

Technical Indicators

Market Signals
Indicator
SLMT
CPHI
Relative Strength Index (RSI) 56.13 44.76
Support Level $3.63 $0.53
Resistance Level $4.60 $0.68
Average True Range (ATR) 0.25 0.07
MACD 0.09 -0.00
Stochastic Oscillator 96.02 23.84

Price Performance

Historical Comparison
SLMT
CPHI

About SLMT Brera Holdings PLC Class B Ordinary Shares

Solmate Infrastructure Public Ltd is a Solana-based crypto infrastructure company with a strategic focus on Abu Dhabi. The group builds high-performance validators that lower latency, expand network reach, and position Abu Dhabi as a world-wide hub for Solana infrastructure. The company creates value by working with its partners to build infrastructure and real hardware for the crypto revolution. Its cutting-edge Solana staking infrastructure will help drive the adoption of the network in the Middle East.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: